RE: The human story6 Dec 2023 09:35
Great post Jersey and agree with what you say.
I would however suggest that it is now coming the time when AS and the BOD have to acknowledge the patience and support of the LTH's by addressing the SP.
Researched LTH's understand that the AVA6k trial has taken years, not because the Co is inefficient, or missing deadlines, but because the trial has been so successful we are into C7 without an MTD found
We accept that many of us are underwater because of the shambles surrounding the LFT and the promise of supplying the sovereign test. Most of us can accept that the Co were caught up in the mismanagement (and perhaps corruption) surrounding government policy, but in the end the SP went to £2.75 and we never saw an approved test
The Co has spent £10's of millions on Launch and the DX division which has had zero impact on the SP. The Science Day was great and very reassuring but the guest speakers made only passing reference to AVCT and the AVA6k trial and again, it had no impact on the SP. Likewise the recent business update, very reassuring, a commitment to not boosting, all fully supported by the researched LTH's but no impact on the SP.
Next week however is billed as a shareholder update. We have been told that we are now entering the 'commercial phase' and assuming the results are as we expect and fully QC'd, I for one am expecting to hear plans on how they are going to address the SP which continues to languish at prices similar to where it was when the trial began.
We've waited long enough and now I feel is time for the Co to reward our patience and tell us what they are planning to do to commercialise their work and hence boost the SP, no woolly generalisations, some clear plans would be great.
Sign In
Follow the stocks
